Tafenoquine
INDICATIONS
FDA
FDA
- Two different brand names were FDA-approved in 2018:
- Krintafel™ — radical cure (prevention of relapse) of Plasmodium vivax malaria in patients ≥16 years old who are receiving chloroquine therapy for acute P. vivax infection.
- Please note that tafenoquine is NOT indicated for the treatment of acute P. vivax malaria.
- Concomitant use with antimalarials other than chloroquine is not recommended because of the risk of P. vivax recurrence.
- Arakoda™ — prophylaxis of malaria in patients ≥18 years of age.
- Krintafel™ — radical cure (prevention of relapse) of Plasmodium vivax malaria in patients ≥16 years old who are receiving chloroquine therapy for acute P. vivax infection.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- P. ovale radical cure:
- Off-label radical cure in patients ≥16 years with normal quantitative G6PD activity when chloroquine/hydroxychloroquine is used for acute therapy.
- Babesia microti babesiosis:
- Investigational salvage therapy for persistent or relapsing infection, particularly in highly immunocompromised patients with failure or resistance to standard regimens.
- Clinical experience is limited to case reports/small case series.
- Tafenoquine is not FDA-approved for babesiosis, and no standardized dose or duration has been established.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: November 7, 2026
Citation
, Caitlin Soto, and Edina Avdic. "Tafenoquine." Johns Hopkins ABX Guide, The Johns Hopkins University, 2026. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540701/all/Tafenoquine.
C, Avdic E. Tafenoquine. Johns Hopkins ABX Guide. The Johns Hopkins University; 2026. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540701/all/Tafenoquine. Accessed November 21, 2026.
, C., & Avdic, E. (2026). Tafenoquine. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540701/all/Tafenoquine
C, Avdic E. Tafenoquine [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2026. [cited 2026 November 21]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540701/all/Tafenoquine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tafenoquine
ID - 540701
A1 - ,Caitlin Soto,PharmD, BCIDP
AU - Avdic,Edina,Pharm.D.
Y1 - 2026/11/07/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540701/all/Tafenoquine
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -

Johns Hopkins ABX Guide

